tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BEAM Stock Latest News

Beam Therapeutics announces upcoming board member resignation
Company AnnouncementsBeam Therapeutics announces upcoming board member resignation
7d ago
8K
BEAM
Beam Therapeutics participates in a conference call with William Blair
PremiumThe Fly
Beam Therapeutics participates in a conference call with William Blair
8d ago
BEAM
Cathie Wood’s ARK Investment buys 116K shares of Beam Therapeutics today
PremiumThe Fly
Cathie Wood’s ARK Investment buys 116K shares of Beam Therapeutics today
14d ago
BEAM
Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI
PremiumMarket News
Cathie Wood Dumps Over $5M in a Biotech Stock, Buys WeRide and Tempus AI
20d ago
U
KDK
Beam Therapeutics: Buy Rating Backed by BEAM-302 Progress, 2026 Data Catalyst, and De-Risked Accelerated Approval Path
PremiumRatings
Beam Therapeutics: Buy Rating Backed by BEAM-302 Progress, 2026 Data Catalyst, and De-Risked Accelerated Approval Path
20d ago
BEAM
Cathie Wood Buys Netflix and AI Stocks, Dumps Beam, PINS, and GitLab Shares
PremiumMarket NewsCathie Wood Buys Netflix and AI Stocks, Dumps Beam, PINS, and GitLab Shares
21d ago
TEM
WRD
Beam Therapeutics: Undervalued Base-Editing Leader with De-Risked BEAM-302 Driving $46 Price Target and Overweight/Buy Rating
Premium
Ratings
Beam Therapeutics: Undervalued Base-Editing Leader with De-Risked BEAM-302 Driving $46 Price Target and Overweight/Buy Rating
22d ago
BEAM
Beam Therapeutics price target raised to $41 from $37 at Bernstein
Premium
The Fly
Beam Therapeutics price target raised to $41 from $37 at Bernstein
22d ago
BEAM
Beam Therapeutics: De-Risked Late-Stage Pipeline, Clear FDA Pathways, and Strong Cash Runway Underscore Buy Rating and $80 Target
PremiumRatings
Beam Therapeutics: De-Risked Late-Stage Pipeline, Clear FDA Pathways, and Strong Cash Runway Underscore Buy Rating and $80 Target
29d ago
BEAM
Beam Therapeutics rises 27.9%
PremiumThe Fly
Beam Therapeutics rises 27.9%
1M ago
BEAM
Beam FDA alignment could accelerate review, says William Blair
PremiumThe Fly
Beam FDA alignment could accelerate review, says William Blair
1M ago
BEAM
Beam Therapeutics higher after reaching FDA alignment on BEAM-302
PremiumThe Fly
Beam Therapeutics higher after reaching FDA alignment on BEAM-302
1M ago
BEAM
Beam Therapeutics rises 23.4%
PremiumThe FlyBeam Therapeutics rises 23.4%
1M ago
BEAM
Beam Therapeutics outlines 2026 strategy and extends runway
Premium
Company Announcements
Beam Therapeutics outlines 2026 strategy and extends runway
1M ago
8K
BEAM
Beam Therapeutics initiated with a Neutral at UBS
Premium
The Fly
Beam Therapeutics initiated with a Neutral at UBS
1M ago
BEAM
Beam Therapeutics price target raised to $45 from $43 at BofA
PremiumThe Fly
Beam Therapeutics price target raised to $45 from $43 at BofA
1M ago
BEAM
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
PremiumMarket News
Cathie Wood Wraps Up 2025 with New Biotech Buys — Here’s What It Sold
1M ago
BEAM
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
PremiumMarket News
Cathie Wood Closes Out 2025 with a Rocket Lab (RKLB) Trim and Fresh Biotech Bets
1M ago
BEAM
IONS
Beam Therapeutics Gains $255M from Orbital Acquisition
PremiumCompany Announcements
Beam Therapeutics Gains $255M from Orbital Acquisition
2M ago
8K
BEAM
Beam Therapeutics’ Promising BEACON Trial and Advanced Manufacturing Boost Buy Rating
PremiumRatingsBeam Therapeutics’ Promising BEACON Trial and Advanced Manufacturing Boost Buy Rating
2M ago
BEAM
Promising Clinical Data and Market Potential Drive Buy Rating for Beam Therapeutics’ Sickle Cell Treatment
Premium
Ratings
Promising Clinical Data and Market Potential Drive Buy Rating for Beam Therapeutics’ Sickle Cell Treatment
2M ago
BEAM
Beam Therapeutics: Promising BEACON Trial Results Support Buy Rating
Premium
Ratings
Beam Therapeutics: Promising BEACON Trial Results Support Buy Rating
2M ago
BEAM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >